Of the tens of millions of Chinese adults at risk for heart disease, only 3% receive treatment to manage that risk, compared to over 25% in the United States.
Radiologists and cardiologists at YSM are among the first ever to use a new personalized cardiac test that can predict the need for cardiac catheterizations.
Being Well at Yale and Yale WorkLife are partnering with sleep experts to offer an informative series of workshops and a “2-Weeks to Better Sleep” Challenge.
Families from Connecticut and Rhode Island will now have close access to pediatric care for congenital heart defects, cardiomyopathy, and other conditions.
Yale researchers identified a new protein that, when downregulated, can result in resistance to BRAF inhibitors, a drug therapy effective in treating melanoma.
More than 70% of researchers fail to reproduce scientists’ experiments — one reason may lie in the significant differences in cell lines used by different labs.
The drug N-acetylcysteine has been shown to decrease mortality and short-term neonatal morbidity in pregnancies complicated by infections or inflammation.
Women’s Health Research at Yale Director Carolyn Mazure spoke at the American Heart Association’s “Go Red for Women” event at The New Haven Lawn Club on Feb. 7.
Wallach, assistant professor of epidemiology in YSM’s Department of Environmental Health Sciences, discusses his research and pizza in New Haven vs. New York.
